GB0812316D0 - Antibody - Google Patents

Antibody

Info

Publication number: GB0812316D0
Authority: GB; United Kingdom
Prior art keywords: antibody
Prior art date: 2008-07-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0812316.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SECR DEFENCE

UK Secretary of State for Defence

Original Assignee

SECR DEFENCE

UK Secretary of State for Defence

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-07

Filing date

2008-07-07

Publication date

2008-08-13

2008-07-07 Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE

2008-07-07 Priority to GBGB0812316.8A priority Critical patent/GB0812316D0/en

2008-08-13 Publication of GB0812316D0 publication Critical patent/GB0812316D0/en

2009-07-07 Priority to PCT/GB2009/001693 priority patent/WO2010004276A2/en

2009-07-07 Priority to GB0911770A priority patent/GB2461635A/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/193—Equine encephalomyelitis virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

GBGB0812316.8A 2008-07-07 2008-07-07 Antibody Ceased GB0812316D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GBGB0812316.8A GB0812316D0 (en)	2008-07-07	2008-07-07	Antibody
PCT/GB2009/001693 WO2010004276A2 (en)	2008-07-07	2009-07-07	Antibody
GB0911770A GB2461635A (en)	2008-07-07	2009-07-07	Functional antibody fragments which bind multiple Venezuelan equine encephalitis virus strains

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0812316.8A GB0812316D0 (en)	2008-07-07	2008-07-07	Antibody

Publications (1)

Publication Number	Publication Date
GB0812316D0 true GB0812316D0 (en)	2008-08-13

Family

ID=39718019

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GBGB0812316.8A Ceased GB0812316D0 (en)	2008-07-07	2008-07-07	Antibody
GB0911770A Withdrawn GB2461635A (en)	2008-07-07	2009-07-07	Functional antibody fragments which bind multiple Venezuelan equine encephalitis virus strains

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB0911770A Withdrawn GB2461635A (en)	2008-07-07	2009-07-07	Functional antibody fragments which bind multiple Venezuelan equine encephalitis virus strains

Country Status (2)

Country	Link
GB (2)	GB0812316D0 (en)
WO (1)	WO2010004276A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2496854A (en) *	2011-11-22	2013-05-29	Secr Defence	Anti-VEEV antibodies and their use in prophylaxis or treatment
US20230065377A1 (en) *	2019-08-31	2023-03-02	Vanderbilt University	Human antibodies to alphaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2374027A1 (en) *	2001-03-13	2002-09-13	The Minister Of National Defence	Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee)
CA2475735A1 (en) *	2002-02-11	2003-09-18	Alexion Pharmaceuticals, Inc.	Immunotherapeutics for biodefense
US20040258699A1 (en) *	2002-02-11	2004-12-23	Bowdish Katherine S.	Immunotherapeutics for biodefense
CA2420829A1 (en) *	2002-03-06	2003-09-06	Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence	Novel fusion protein of human igg1 heavy chain constant region and scfv antibody against venezuelan equine encephalitis virus
CA2485342A1 (en) *	2002-05-13	2004-05-13	Alexion Pharmaceuticals, Inc.	Humanized antibodies against the venezuelan equine encephalitis virus
CA2462343A1 (en) *	2003-03-25	2004-09-25	Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence	Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of venezuelan equine encephalitis virus

2008
- 2008-07-07 GB GBGB0812316.8A patent/GB0812316D0/en not_active Ceased
2009
- 2009-07-07 WO PCT/GB2009/001693 patent/WO2010004276A2/en active Application Filing
- 2009-07-07 GB GB0911770A patent/GB2461635A/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO2010004276A2 (en)	2010-01-14
WO2010004276A3 (en)	2010-04-29
GB0911770D0 (en)	2009-08-19
GB2461635A (en)	2010-01-13

Publication	Publication Date	Title
IL276622A (en)	2020-09-30	Antibody formulation
EP2241578A4 (en)	2012-09-12	Anti-cldn6 antibody
ZA201102119B (en)	2011-12-28	Improved antibody libraies
SI2146745T1 (en)	2015-10-30	penta-specific antibody
GB0821100D0 (en)	2008-12-24	Antibodies
GB0708002D0 (en)	2007-06-06	Antibodies
EP2138576A4 (en)	2011-02-23	Anti-claudin-4 antibody
ZA201104545B (en)	2012-03-28	Anti-siglec-15 antibody
IL214996A0 (en)	2011-11-30	Anti-bcma antibodies
GB0920127D0 (en)	2009-12-30	Antibodies
GB0909906D0 (en)	2009-07-22	Antibodies
EP2427496A4 (en)	2013-05-15	Anti-vegf-d antibodies
IL205073A0 (en)	2010-11-30	Anti-bst2 antibody
GB0718737D0 (en)	2007-11-07	Antibodies
ZA201006099B (en)	2012-01-25	Anti-tyrp1 antibodies
GB0920324D0 (en)	2010-01-06	Antibodies
HK1170745A1 (en)	2013-03-08	Antibodies against il-17br il-17br
ZA201007976B (en)	2012-02-29	Anti-pirb antibodies
GB0818356D0 (en)	2008-11-12	Antibodies
EP2499256A4 (en)	2013-09-11	Anti-c-mpl antibodies
GB2473934B (en)	2012-11-28	Anti-VEEV antibody
GB0911770D0 (en)	2009-08-19	Antibody
EP2264071A4 (en)	2011-05-04	Antibody having an immune-enhancement function
GB0817622D0 (en)	2008-11-05	Antibody
GB0817621D0 (en)	2008-11-05	Antibody

Legal Events

Date	Code	Title	Description
2009-08-19	AT	Applications terminated before publication under section 16(1)